School-age follow-up of an RCT in very preterm infants at high risk of BPD (545 of 674 eligible analysed): neonatal hydrocortisone vs placebo did not change functional impairment (71.3% vs 73.3%; adjusted RR 0.99) or its components.
RCTn = 545
DeMauro et al. Hydrocortisone in Preterm Infants and School-Age Functional Outcomes: Follow-Up of a Randomized Clinical Trial